0769-39003909
Recently, President Wang Hu of Dongguan Humen Aier Eye Hospital has officially been appointed as a member of the DIP Payment Reform Expert Pool set up by the Dongguan Municipal Healthcare Security Bureau. He is the third expert from Aier Eye Hospital within the Dongguan region to receive this honour, following President Liu Fei of Dongguan Aier Eye Hospital and Director Ouyang Pengcheng from the Medical Insurance Office. The selection of the three experts stands not only as their personal professional achievement, but also authoritative recognition of the pioneering role of Aier Eye Hospital Dongguan Region in the in‑depth integration of medical administration, medical insurance coordination and clinical practice.

In Dongguan, experts from Aier Eye Hospital have formed a distinctive joint force for medical‑insurance reform. President Liu Fei provides strategic insights from the perspective of regional development and clinical excellence. Drawing on hands‑on hospital‑management experience, President Wang Hu focuses on operational quality improvement and efficiency enhancement under the DIP framework. Director Ouyang Pengcheng contributes professional expertise in policy implementation and procedural optimization. Their joint efforts serve one shared goal: to achieve more efficient utilization of medical‑insurance funds, deliver better medical experiences for patients, and foster sustainable hospital development.

Products listed on the procurement platform are sold at their listed prices: all drugs and consumables listed on the procurement platform are strictly priced at the official listed rates, ensuring patients have access to high‑quality products at substantially reduced prices.
Non‑listed products are sold with zero markup: drugs and consumables not available on the platform are sold without any price markup, relieving patients’ worries over price comparisons across different hospitals and enabling a fair and transparent pricing environment.
The “no traceability code, no procurement” rule is enforced for pharmaceutical purchases: all procured medicines must carry valid drug traceability codes, enforcing the principle of “no procurement, no acceptance and no payment without traceability codes” for medical‑insurance‑covered drugs so as to safeguard public health interests.

“With the implementation of these pricing policies for drugs and medical consumables, commonly used eye drops, intraocular lenses for cataract surgery and high‑value consumables for vitreoretinal procedures have all seen comprehensive price cuts at our hospital. In the long run, delivering benefits to the public creates a favourable medical‑care environment and facilitates sound, sustainable development. Meanwhile, this helps hospitals optimize cost structures and improve operational efficiency, laying a solid foundation for the smooth advancement of DIP payment reform,” commented President Wang Hu on the rationale behind the price reform.

“Promote standardization and benefit the people” perfectly sums up the far‑reaching significance of DIP payment reform and embodies the operational philosophy of Aier Eye Hospital. We firmly believe that payment‑method reform ultimately aims to restore the intrinsic value of medical services.
Going forward, Aier Eye Hospital in Dongguan will keep actively engaging in and advancing the deepening of DIP payment reform. It strives to build a win‑win scenario featuring improved hospital management, higher efficiency of medical‑insurance funds and greater benefits for patients. It will ensure that gains from medical development truly reach thousands of households and contribute to the building of a “Healthy Dongguan”.